TNF and rheumatoid arthritis: The results of the ANTARES study of anti-TNF therapies suggest that TNF-blocking drugs work by blocking the conversion of hormones from androgens (anti-inflammatory) to estrogens (pro-inflammatory) in the synovium of RA patients.